Selecta Biosciences Funding: $151M Raised, Series E (2015)
Selecta Biosciences has raised $151M in total funding. Latest round: Series E. Backed by OrbiMed, 5AM Ventures, Advent Life Sciences.
Selecta Biosciences funding overview
Selecta Biosciences has raised $151M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in September 2015. The round record for Selecta Biosciences runs through 2015; nothing later has been disclosed. Investors on record include OrbiMed, 5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures and 10 others. 16 distinct backers are named across the disclosed rounds.
Frequently asked about Selecta Biosciences funding
How much has Selecta Biosciences raised?
Selecta Biosciences has raised $151M in total disclosed funding across the rounds on record.
Who has invested in Selecta Biosciences?
OrbiMed, 5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures are named among the investors backing Selecta Biosciences.
What was the latest Selecta Biosciences funding round?
The most recent disclosed round is a Series E, announced in September 2015.
Where is Selecta Biosciences based?
No headquarters location is disclosed for Selecta Biosciences.
When did Selecta Biosciences last raise?
The last disclosed Selecta Biosciences round closed in September 2015 at Series E.
Totals shown for Selecta Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
